RXi Pharmaceuticals, with an Innovation Platform that Could Change Medicine, CEO Clip Video

Vancouver, British Columbia--(Newsfile Corp. - June 1, 2015) - President & CEO, of RXi Pharmaceuticals (NASDAQ: RXII), Geert Cauwenbergh explains this biotechnology company and their innovative platforms that could change medicine.

If you cannot view the video above, please visit:
http://www.b-tv.com/rxi-pharma-ceo-clip/

RXi Pharmacueticals will be featured on CBC's Documentary Channel beginning Jun 8, 2015, Monday through Friday, throughout the day and evenings.

About RXi Pharmaceuticals (NASDAQ: RXII)

RXi Pharmaceuticals Corporation is a biotechnology company focused on discovering and developing innovative therapeutics, primarily in the area of dermatology and ophthalmology, addressing high-unmet medical needs. Their discovery and clinical development programs are based on siRNA technology as well as immunotherapy agents. RXi's robust pipeline, coupled with an extensive patent portfolio, provides for product and business development opportunities across a broad spectrum. http://www.rxipharma.com/

About CEO Clips:

CEO Clips is the largest library of publicly traded company CEO videos in the US and Canada. These 90 second video profiles broadcast on national TV and are distributed online on top financial portals including: Thomson Reuters, BNN.ca, Stockhouse.com and CBJ.ca. They are also disseminated via a video news release to several financial portals including Globe Investor, OTC Markets, TMX Money, and The National Post.

BTV - Business Television/CEO Clip Contact: Trina Schlingmann (604) 664-7401 x 5 trina@b-tv.com